Lophora
Company Details
Status: Private
Employees: 1-10
Location:
Gentofte, Denmark
Type:
sample
Technology:
sample
About: Lophora is a clinical-stage CNS drug discovery company developing novel, next generation psychedelic medicines to treat a multitude of psychiatric disorders
www.lophora.com
Founded in 2018 Lophora has successfully finished initial characterization of its lead-candidate LPH-5 through funding granted by the BII (Novo Nordisk Foundation), public funds and experienced biotech investors. Lophora will initiate first-in-human trials by 2024.
Efficacy of LPH-5 has been extensively characterized in vivo and has successfully completed GLP-Tox with expected CTA submission by Q2 2024.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Lophora | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.